Skip navigation

Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

Kim, Yang-Hee, Kanczler, Janos M., Lanham, Stuart, Rawlings, Andrew, Roldo, Marta, Tozzi, Gianluca, Dawson, Jonathan I., Cidonio, Gianluca ORCID: 0000-0002-9445-6994 and Oreffo, Richard O. C. ORCID: 0000-0001-5995-6726 (2024) Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells. Bio-Design and Manufacturing. ISSN 2096-5524 (Print), 2522-8552 (Online) (doi:https://doi.org/10.1007/s42242-023-00265-z)

[img]
Preview
PDF (Publisher VoR)
46126_TOZZI_Biofabrication_of_nanocomposite-based_scaffolds_containing_human_bone_extracellular_matrix.pdf - Published Version
Available under License Creative Commons Attribution.

Download (5MB) | Preview

Abstract

Autograft or metal implants are routinely used in skeletal repair. However, they fail to provide long-term clinical resolution, necessitating a functional biomimetic tissue engineering alternative. The use of native human bone tissue for synthesizing a biomimetic material ink for three-dimensional (3D) bioprinting of skeletal tissue is an attractive strategy for tissue regeneration. Thus, human bone extracellular matrix (bone-ECM) offers an exciting potential for the development of an appropriate microenvironment for human bone marrow stromal cells (HBMSCs) to proliferate and differentiate along the osteogenic lineage. In this study, we engineered a novel material ink (LAB) by blending human bone-ECM (B) with nanoclay (L, Laponite® ) and alginate (A) polymers using extrusion-based deposition. The inclusion of the nanofiller and polymeric material increased the rheology, printability, and drug retention properties and, critically, the preservation of HBMSCs viability upon printing. The composite of human bone-ECM-based 3D constructs containing vascular endothelial growth factor (VEGF) enhanced vascularization after implantation in an ex vivo chick chorioallantoic membrane (CAM) model. The inclusion of bone morphogenetic protein-2 (BMP-2) with the HBMSCs further enhanced vascularization and mineralization after only seven days. This study demonstrates the synergistic combination of nanoclay with biomimetic materials (alginate and bone- ECM) to support the formation of osteogenic tissue both in vitro and ex vivo and offers a promising novel 3D bioprinting approach to personalized skeletal tissue repair.

Item Type: Article
Uncontrolled Keywords: extracellular matrix; nanoclay; bone; 3D bioprinting
Subjects: Q Science > Q Science (General)
T Technology > T Technology (General)
Faculty / School / Research Centre / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Engineering (ENG)
Last Modified: 05 Mar 2024 13:55
URI: http://gala.gre.ac.uk/id/eprint/46126

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics